Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma

BACKGROUND: Head and neck squamous cell carcinomas (HNSCCs) are highly lethal epithelial tumours containing self-renewal cancer stem cells (CSCs). CSCs in HNSCCs are strongly associated with tumour initiation, invasion, and chemoradiation resistance. However, the important factors regulating stemnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Woo Jin, Koo, Bon Seok, Lee, Sang Hyuk, Kim, Jin Man, Rho, Young Soo, Lim, Jae Yol, Moon, Jung Hwa, Cho, Jae Hoon, Lim, Young Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729481/
https://www.ncbi.nlm.nih.gov/pubmed/29096401
http://dx.doi.org/10.1038/bjc.2017.373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729481/
https://www.ncbi.nlm.nih.gov/pubmed/29096401
http://dx.doi.org/10.1038/bjc.2017.373

Ejemplares similares